triamcinolone acetonide

Modality

small molecule

Mechanism

—

Targets

—

Storage

—

Approved

atopic dermatitis — FDA · alopecia areata — FDA

In trial

alopecia areata, psoriasis, atopic dermatitis, vitiligo, hidradenitis suppurativa, prurigo nodularis

Sources

Last verified

2026-10-11

No curated MOA diagram yet. See lib/moa-data.ts for the shape; add an entry keyed by triamcinolone acetonide.

Formulations

0.025% / 0.1% / 0.5% cream / ointment / lotion10 mg/mL + 40 mg/mL injectable suspension (intralesional)